We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Hitachi and Axcelead have entered a partnership to develop solutions contributing to more efficient creation of next-generation biopharmaceuticals with digital technology and drug discovery.
Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.